SJS Investment Consulting’s Abeona Therapeutics ABEO Stock Holding History
Bought
Maintained
Sold
Other funds holding ABEO
ACM
AIC
SJS Investment Consulting's ABEO Position: Q3 2026 in Review
SJS Investment Consulting increased its Abeona Therapeutics (ABEO) stake by 855% in Q3 2026, buying an estimated $1.06K and bringing the position to 191 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2495.
SJS Investment Consulting first reported a position in ABEO in Q2 2026 and has held it in 2 quarters since. 114 funds tracked by Wall St. Rank hold ABEO as of Q3 2026.
- SJS Investment Consulting held 191 shares of Abeona Therapeutics worth $1K as of Q3 2026.
- SJS Investment Consulting bought 171 Abeona Therapeutics shares in Q3 2026, an estimated $1.06K.
- Abeona Therapeutics made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #2495 holding.
- SJS Investment Consulting first reported a position in Abeona Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 114 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2026.
Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.